Headlines: Additional $144.1 Million Awarded for Opioid Crisis

SAMHSA Headlines

September 18, 2017

SAMHSA Headlines—Your one-stop source for the latest from SAMHSA.
Funding   |    Data   |    Resources   |    Events    |    SAMHSA News


Additional Funding of $144.1 Million Awarded for Addressing Opioid Crisis

The U.S. Department of Health and Human Services has awarded an additional $144.1 million in grants to prevent and treat opioid addiction. The grants are administered by SAMHSA.

$14.5 Million in Grants Awarded for Suicide Prevention Programs

SAMHSA announced the funding of up to $14.5 million in grants over several years for suicide prevention programs. The grant programs included in this SAMHSA effort are Zero Suicide and Cooperative Agreements To Implement the National Strategy for Suicide Prevention.

Texas and Louisiana May Reallocate Certain Federal Funds To Provide Addiction Medication

Federal and state governments are working to ensure opioid treatment is available in the wake of Hurricane Harvey. States can reallocate previously awarded formula and discretionary grants to provide opioid use disorder treatment when no other funds are available. The decision will help people in affected areas of Texas and Louisiana, where thousands have been displaced by storms.


New Report on Key Substance Use and Mental Health Indicators in the United States: Results From the 2016 National Survey on Drug Use and Health (NSDUH)

SAMHSA's National Survey on Drug Use and Health (NSDUH) report provides the latest estimates on substance use and mental health in the nation, including the misuse of opioids. Opioids include heroin use and pain reliever misuse. In 2016, there were 11.8 million people age 12 or older who misused opioids in the past year. The majority of those individuals misused pain relievers rather than used heroin—there were 11.5 million people who misused pain relievers and 948,000 people who used heroin.

New Report on Trends in the Use of Methadone, Buprenorphine, and Extended-Release Naltrexone at Substance Abuse Treatment Facilities

A new report from SAMHSA shows the number of Opioid Treatment Programs (OTPs) has increased from approximately 1,100 in 2003 to almost 1,500 by the end of 2016. The number of clients receiving methadone on the survey reference date increased from about 227,000 in 2003 to over 350,000 in 2015. OTPs are regulated by SAMHSA and are qualified to dispense the controlled substances, methadone and buprenorphine, to treat addiction to opioids (e.g., heroin and prescription pain relievers).


Roadmap to Behavioral Health: A Guide to Using Mental Health and Substance Use Disorder Services [PDF – 1MB]

The Centers for Medicare & Medicaid Services and SAMHSA recently released a new publication titled, Roadmap to Behavioral Health: A Guide to Using Mental Health and Substance Use Disorder Services. The publication is designed to serve as a behavioral health resource for consumers and offers important information about mental health and substance use disorder services, including definitions of behavioral health terms and guidance on how to find a behavioral health services provider, receive treatment, and obtain follow-up care.


September 27, 2017

Recovery, Prevention, & Hope: National Experts on Opioids and Other Addictions Equip Faith and Community Leaders

Live from Washington, DC, the U.S. Department of Health and Human Services will convene national leaders and experts to talk about the opioid epidemic and other addictions to raise awareness, encourage compassion, reinforce the role of community and families in long-term recovery and prevention, and make a call to action. This live stream will be from 1 to 2 p.m. Eastern Time.


An adult teaching two kids.

Dr. McCance-Katz Appointed Assistant Secretary for Mental Health and Substance Use

This position was created under the 21st Century Cures Act and will support behavioral health priorities including the opioid epidemic.